Mohit Kaushal's most recent trade in Oncology Institute Inc (The) was a trade of 56,000 Common stock done . Disclosure was reported to the exchange on Nov. 22, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oncology Institute Inc (The) | Mohit Kaushal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2024 | 56,000 | 177,253 | - | 0 | Common stock | |
| Oncology Institute Inc (The) | Mohit Kaushal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Dec 2023 | 53,326 | 121,253 | - | 0 | Common stock | |
| Oncology Institute Inc (The) | Mohit Kaushal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 19,685 | 42,393 | - | 0 | Common stock | |
| Oncology Institute Inc (The) | Mohit Kaushal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 22,708 | 48,242 | - | 0 | Common Stock | |
| Oncology Institute Inc (The) | Mohit Kaushal | Director | Sale of securities on an exchange or to another person at price $ 2.13 per share. | 14 Nov 2022 | 15,994 | 25,534 | - | 2.1 | 34,083 | Common Stock |
| Oncology Institute Inc (The) | Mohit Kaushal | Director | Sale of securities on an exchange or to another person at price $ 4.96 per share. | 24 Oct 2022 | 4,798 | 41,528 | - | 5.0 | 23,798 | Common stock |
| Oncology Institute Inc (The) | Mohit Kaushal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 15,994 | 41,528 | - | 0 | Common stock | |
| Oncology Institute Inc (The) | Mohit Kaushal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 4,798 | 46,326 | - | 0 | Common stock | |
| Oncology Institute Inc (The) | Mohit Kaushal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2021 | 30,000 | 0 | - | - | Class B Common Stock | |
| Oncology Institute Inc (The) | Mohit Kaushal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2021 | 30,000 | 30,000 | - | - | Common Stock |